ascopubs.org

A phase III multicenter randomized non-inferiority trial comparing selective versus modified neck dissection in node-positive oral squamous cell carcinoma (SND vs MND).

FIERCE-HN: A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of ficlatuzumab (HGF/cMET mAb) in combination with cetuximab in participants with recurrent or metastatic (R/M) ...
Nature

Neck dissection improves the prognosis of patients with early-stage oral squamous cell carcinoma

Oral squamous cell carcinoma (OSCC) is the most prevalent malignant neoplasm in the head and neck region, and given its significant impact on patients’ facial structures and physiological functions, ...
ascopubs.org

Can Elective Neck Dissection for Oral Cancer Be Planned on the Basis of Depth of Invasion? Retrospective Analysis

Triple Oral Metronomic Chemotherapy Versus Chemotherapy of Physician Discretion After Failure of Platinum-Based Therapy in Advanced Head and Neck Cancer: A Phase III Randomized Study (METRO-CHASE ...
Nature

Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinoma

This sentinel node (SN) biopsy trial aimed to assess its effectiveness in identifying predictive factors of micrometastases and to determine whether elective neck dissection is necessary in oral ...